Enovis (ENOV) Latest Stock Analysis Report – Oct 15, 2026, 4:00 PM ET
Updated Oct 15, 2026, 4:00 PM ET
- Closed at $19.35, +4.20% vs the prior close of $18.57.
- Volume 1.29M shares, 0.8x its 50-day average.
- No new SEC filings since the prior session.
- No new insider buys or sales reported since the prior session.
ENOV jumps 4.2% to $19.35, a 1-month high. Closed at $19.35, +4.20% vs the prior close of $18.57. Day range $18.42–$19.44, opened at $18.76.
ENOV daily analysis — what happened
A plain-English, data-only note written after every US trading day. Newest first; older days stay archived below.
Oct 15, 2026 — ENOV jumps 4.2% to $19.35, a 1-month high
- Closed at $19.35, +4.20% vs the prior close of $18.57. Day range $18.42–$19.44, opened at $18.76.
- Volume was 1.29M shares, 0.8x its 50-day average of 1.61M.
- Price is -7.9% vs its 50-day average ($21.01) and -17.3% vs its 200-day average ($23.41).
- 52-week range $16.70–$34.28; today's close sits at 15% of that range, 43.6% below the 52-week high.
Oct 14, 2026 — ENOV dips 2.2% to $18.57
- Closed at $18.57, -2.21% vs the prior close of $18.99. Day range $18.24–$18.85, opened at $18.74.
- Volume was 1.14M shares, 0.7x its 50-day average of 1.61M.
- Price is -12.5% vs its 50-day average ($21.23) and -20.8% vs its 200-day average ($23.45).
- 52-week range $16.70–$34.28; today's close sits at 11% of that range, 45.8% below the 52-week high.
Oct 13, 2026 — ENOV jumps 4.1% to $18.99, a 1-month high, 3 up days in a row
- Closed at $18.99, +4.05% vs the prior close of $18.25. Day range $18.18–$19.12, opened at $18.50.
- Volume was 1.41M shares, 0.9x its 50-day average of 1.61M.
- Price is -11.6% vs its 50-day average ($21.47) and -19.2% vs its 200-day average ($23.49).
- 52-week range $16.70–$34.28; today's close sits at 13% of that range, 44.6% below the 52-week high.
- That makes 3 straight gains.
Oct 12, 2026 — ENOV jumps 3.2% to $18.25
- Closed at $18.25, +3.17% vs the prior close of $17.69. Day range $17.36–$18.40, opened at $17.47.
- Volume was 910.90K shares, 0.6x its 50-day average of 1.61M — lighter than usual.
- Price is -16.0% vs its 50-day average ($21.72) and -22.4% vs its 200-day average ($23.53).
- 52-week range $16.70–$34.28; today's close sits at 9% of that range, 46.8% below the 52-week high.
Oct 9, 2026 — ENOV rises 1.5% to $17.69
- Closed at $17.69, +1.49% vs the prior close of $17.43. Day range $17.15–$17.89, opened at $17.60.
- Volume was 1.15M shares, 0.7x its 50-day average of 1.61M.
- Price is -19.4% vs its 50-day average ($21.94) and -24.9% vs its 200-day average ($23.57).
- 52-week range $16.70–$34.28; today's close sits at 6% of that range, 48.4% below the 52-week high.
Oct 8, 2026 — ENOV dips 1.0% to $17.43, a 52-week low, 3 down days in a row
- Closed at $17.43, -1.02% vs the prior close of $17.61. Day range $16.70–$17.63, opened at $17.35.
- Volume was 2.31M shares, 1.5x its 50-day average of 1.58M.
- Price is -21.4% vs its 50-day average ($22.17) and -26.2% vs its 200-day average ($23.62).
- 52-week range $16.70–$34.28; today's close sits at 4% of that range, 49.2% below the 52-week high.
- That makes 3 straight losses.
Oct 7, 2026 — ENOV slides 3.2% to $17.61, a 52-week low
- Closed at $17.61, -3.24% vs the prior close of $18.20. Day range $17.53–$18.13, opened at $18.03.
- Volume was 1.29M shares, 0.8x its 50-day average of 1.58M.
- Price is -21.5% vs its 50-day average ($22.43) and -25.6% vs its 200-day average ($23.66).
- 52-week range $17.30–$34.28; today's close sits at 2% of that range, 48.6% below the 52-week high.
Oct 6, 2026 — ENOV dips 2.6% to $18.20
- Closed at $18.20, -2.62% vs the prior close of $18.69. Day range $18.06–$19.01, opened at $19.01.
- Volume was 1.02M shares, 0.6x its 50-day average of 1.58M.
- Price is -19.7% vs its 50-day average ($22.67) and -23.2% vs its 200-day average ($23.71).
- 52-week range $17.30–$34.28; today's close sits at 5% of that range, 46.9% below the 52-week high.
Oct 5, 2026 — ENOV jumps 5.2% to $18.69
- Closed at $18.69, +5.18% vs the prior close of $17.77. Day range $17.56–$18.96, opened at $17.70.
- Volume was 1.36M shares, 0.9x its 50-day average of 1.57M.
- Price is -18.3% vs its 50-day average ($22.87) and -21.3% vs its 200-day average ($23.76).
- 52-week range $17.30–$34.28; today's close sits at 8% of that range, 45.5% below the 52-week high.
Oct 2, 2026 — ENOV dips 1.6% to $17.77, a 52-week low, 3 down days in a row
- Closed at $17.77, -1.55% vs the prior close of $18.05. Day range $17.68–$18.27, opened at $18.27.
- Volume was 1.37M shares, 0.9x its 50-day average of 1.56M.
- Price is -22.9% vs its 50-day average ($23.04) and -25.3% vs its 200-day average ($23.80).
- 52-week range $17.30–$34.28; today's close sits at 3% of that range, 48.2% below the 52-week high.
- That makes 3 straight losses.
ENOV latest news & SEC filings
Every SEC filing by or about ENOV in the last 120 days, explained in plain English. Updated daily, with a same-day refresh for new filings.
Oct 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Ortiz Christine received an award of 958 shares on Sep 30, 2026; now holds 26,815
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 8, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Engert Oliver bought 2,660 shares at $18.80 (≈$50.01K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Engert Oliver bought 5,140 shares at $19.46 (≈$100.02K) on Sep 3, 2026
- Engert Oliver bought 2,458 shares at $20.32 (≈$49.95K) on Sep 2, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 4, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
- Mcdonald Damien bought 13,035 shares at $19.15 (≈$249.62K) on Sep 4, 2026
Open-market purchases (P) and sales (S) are shown in colour; awards, exercises and tax withholding are routine pay-related moves. Many sales are pre-planned under 10b5-1 plans.
Sep 1, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 7.01 — Released information under Regulation FD (e.g. a presentation or press release).
Aug 14, 2026 · Form SCHEDULE 13G — Passive stake (13G)
Passive stake (13G) — an investor reported owning more than 5%
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Aug 6, 2026 · Form 10-Q — Quarterly report
Quarterly report (unaudited financial statements for the quarter)
Quarter ended Jul 3, 2026:
- Revenue: $582.78M (prior year $564.54M) (+3.2% vs Jul 4, 2025)
- Net income: -$1.19M (prior year -$36.74M) (loss narrowed vs Jul 4, 2025)
- Diluted EPS: -$0.02 (prior year -$0.64) (loss narrowed vs Jul 4, 2025)
Aug 6, 2026 · Form 8-K — Major event / current report
Current report — a filing companies must make within 4 business days of a major event
- Item 2.02 — Reported results of operations (earnings release).
This is a results-day filing: the earnings press release is attached as an exhibit.
Jul 28, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 8, 2026 · Form SCHEDULE 13G/A — Update to a passive 5%+ stake (13G)
Update to a passive 5%+ stake (13G)
Filed by an outside investor (not the company). It reports a holding of more than 5% of a share class; percentage and holder name are in the filing.
Jul 1, 2026 · Form 4 — Insider trade
Insider trade report (Form 4) — a director, officer or 10%+ owner changed their holdings
Insider holdings update with no common-stock transactions in the table (often options or derivative awards only).
Jun 26, 2026 · Form 11-K — Annual report for an employee stock plan
Annual report for an employee stock plan
Things to know before you trade ENOV
- Last results release: Aug 6, 2026 (8-K Item 2.02). Previous ones: May 7, 2026, Feb 26, 2026, Nov 6, 2025. Based on that rhythm, the next report is likely around Nov 5, 2026 — an estimate, not a confirmed date.
- How much it moves: over the last 20 sessions the average daily move was 1.98% (largest 5.2%).
- Liquidity: about 1.55M shares (≈$29.99M) trade per day on average.
- 52-week position: $19.35 vs a range of $16.70–$34.28 (15% of the range).
- Dividends: no cash dividends in the last 2 years.
- Splits: none in the last 2 years.
- Insider trades (Form 4, last 12 months, recent 25 shown): 18 open-market buys, 4 sales; latest: Oliver Engert bought 2,660 shares on Sep 4, 2026.
- Latest filings: 8-K Sep 1, 2026; 10-Q Aug 6, 2026; 8-K Aug 6, 2026.
- Share count: 57.67M shares outstanding (Jul 31, 2026), +0.9% vs a year earlier.
- Listing: NYSE · industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies.
ENOV market data (last 20 sessions)
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 15, 2026 | 18.76 | 19.44 | 18.42 | 19.35 | 1.29M |
| Oct 14, 2026 | 18.74 | 18.85 | 18.24 | 18.57 | 1.14M |
| Oct 13, 2026 | 18.50 | 19.12 | 18.18 | 18.99 | 1.41M |
| Oct 12, 2026 | 17.47 | 18.40 | 17.36 | 18.25 | 910.90K |
| Oct 9, 2026 | 17.60 | 17.89 | 17.15 | 17.69 | 1.15M |
| Oct 8, 2026 | 17.35 | 17.63 | 16.70 | 17.43 | 2.31M |
| Oct 7, 2026 | 18.03 | 18.13 | 17.53 | 17.61 | 1.29M |
| Oct 6, 2026 | 19.01 | 19.01 | 18.06 | 18.20 | 1.02M |
| Oct 5, 2026 | 17.70 | 18.96 | 17.56 | 18.69 | 1.36M |
| Oct 2, 2026 | 18.27 | 18.27 | 17.68 | 17.77 | 1.37M |
| Oct 1, 2026 | 18.19 | 18.51 | 17.74 | 18.05 | 1.59M |
| Sep 30, 2026 | 18.51 | 18.70 | 18.08 | 18.27 | 1.94M |
| Sep 29, 2026 | 18.00 | 18.63 | 17.88 | 18.46 | 1.53M |
| Sep 28, 2026 | 18.28 | 18.46 | 17.97 | 18.16 | 1.47M |
| Sep 25, 2026 | 18.31 | 18.79 | 18.06 | 18.46 | 1.29M |
| Sep 24, 2026 | 18.32 | 18.50 | 17.68 | 18.27 | 1.72M |
| Sep 23, 2026 | 18.29 | 18.56 | 17.86 | 18.24 | 1.18M |
| Sep 22, 2026 | 18.45 | 18.65 | 18.13 | 18.39 | 1.79M |
| Sep 21, 2026 | 18.18 | 18.18 | 17.48 | 18.04 | 2.59M |
| Sep 18, 2026 | 17.70 | 18.09 | 17.47 | 18.04 | 2.65M |
About Enovis
Enovis (ENOV) is listed on the NYSE and classified by the SEC under “Orthopedic, Prosthetic & Surgical Appliances & Supplies”. Its business address is in LEWISVILLE, TX. State of incorporation: DE. Fiscal year ends December 31. SEC CIK 1420800.
ENOV board of directors & executives
From SEC Form 3/4/5 insider filings made in the last 12 months (date = latest filing).
Directors
| Name | Role | Latest filing |
|---|---|---|
| Barbara W. Bodem | Director | May 21, 2026 |
| Liam Kelly | Director | May 21, 2026 |
| Angela S Lalor | Director | May 21, 2026 |
| Damien Mcdonald | Chief Executive Officer | Sep 4, 2026 |
| Philip Okala | Director | May 21, 2026 |
| Christine Ortiz | Director | Jul 1, 2026 |
| A Clayton Perfall | Director | May 21, 2026 |
| Brady Shirley | Director | May 21, 2026 |
| Rajiv Vinnakota | Director | May 21, 2026 |
| Sharon L Wienbar | Director | May 21, 2026 |
Executive officers
| Name | Title | Latest filing |
|---|---|---|
| Phillip Benjamin (Ben) Berry | SVP, Chief Financial Officer | May 14, 2026 |
| Oliver Engert | Chief Administrative Officer | Sep 8, 2026 |
| John Kleckner | Principal Accounting Officer | Mar 10, 2026 |
| Patricia A Lang | SVP, Chief HR Officer | Mar 10, 2026 |
| Damien Mcdonald | Chief Executive Officer | Sep 4, 2026 |
| Terry D Ross | GROUP PRESIDENT, P&R | Mar 10, 2026 |
| Laura Lee Singleton | SVP, Chief HR Officer | Apr 10, 2026 |
| Bradley J Tandy | SVP and Chief Legal Officer | Mar 10, 2026 |
| Louis Vogt | GROUP PRESIDENT, RECON | Mar 10, 2026 |
Recent insider buys & sales
| Date | Insider | Type | Shares | Price |
|---|---|---|---|---|
| Sep 4, 2026 | Oliver Engert | Buy | 2,660 | $18.80 |
| Sep 4, 2026 | Damien Mcdonald | Buy | 13,035 | $19.15 |
| Sep 3, 2026 | Oliver Engert | Buy | 5,140 | $19.46 |
| Sep 2, 2026 | Oliver Engert | Buy | 2,458 | $20.32 |
| Jun 15, 2026 | Oliver Engert | Buy | 1,000 | $20.92 |
| Jun 11, 2026 | Oliver Engert | Buy | 1,000 | $21.75 |
| Jun 11, 2026 | Oliver Engert | Buy | 200 | $20.99 |
| Jun 10, 2026 | Oliver Engert | Buy | 1,000 | $23.00 |
| Jun 1, 2026 | Oliver Engert | Buy | 1,000 | $22.22 |
| Mar 13, 2026 | Oliver Engert | Buy | 1,000 | $23.74 |
| Mar 10, 2026 | Oliver Engert | Buy | 1,000 | $23.93 |
| Mar 9, 2026 | Oliver Engert | Buy | 1,000 | $23.39 |
| Mar 6, 2026 | Oliver Engert | Buy | 250 | $24.28 |
| Mar 6, 2026 | Oliver Engert | Buy | 500 | $24.48 |
| Mar 4, 2026 | Oliver Engert | Buy | 250 | $25.10 |
ENOV financials (annual, from XBRL filings)
| Fiscal year end | Revenue | Net income | Diluted EPS | Operating cash flow |
|---|---|---|---|---|
| Dec 31, 2025 | $2.25B | $-1.18B | -20.75 | $217.29M |
| Dec 31, 2024 | $2.11B | $-825.49M | -14.93 | $113.50M |
| Dec 31, 2023 | $1.71B | $-33.26M | -0.61 | $134.99M |
| Dec 31, 2022 | $1.56B | $-13.29M | -0.25 | $-55.86M |
| Dec 31, 2021 | $1.43B | $71.66M | 1.40 | $356.10M |
Latest balance sheet: total assets $3.77B, total liabilities $2.29B, cash $12.56M (as of Jul 3, 2026).
ENOV earnings / results-day log
| Date | Filing | Close that day |
|---|---|---|
| Aug 6, 2026 | 8-K Item 2.02 (results) | $26.31 |
| May 7, 2026 | 8-K Item 2.02 (results) | $27.25 |
| Feb 26, 2026 | 8-K Item 2.02 (results) | $25.42 |
| Nov 6, 2025 | 8-K Item 2.02 (results) | $28.42 |
| Aug 7, 2025 | 8-K Item 2.02 (results) | $28.52 |
| May 8, 2025 | 8-K Item 2.02 (results) | $33.08 |
| Feb 26, 2025 | 8-K Item 2.02 (results) | $40.00 |
| Nov 6, 2024 | 8-K Item 2.02 (results) | $46.90 |
| Aug 7, 2024 | 8-K Item 2.02 (results) | — |
| May 2, 2024 | 8-K Item 2.02 (results) | — |
| Feb 22, 2024 | 8-K Item 2.02 (results) | — |
| Nov 7, 2023 | 8-K Item 2.02 (results) | — |
Related stocks · Orthopedic, Prosthetic & Surgical Appliances & Supplies
Intuitive Surgical (ISRG)Edwards Lifesciences (EW)Steris (STE)Zimmer Biomet (ZBH)Align Technology (ALGN)Smith & Nephew (SNN)MSA Safety (MSA)Establishment Labs (ESTA)Cadre (CDRE)Sanara MedTech (SMTI)
Popular today
Micron Technology (MU)Spdr S&P 500 Etf (SPY)Nvidia (NVDA)Sandisk (SNDK)AMD (AMD)Space Exploration Technologies (SPCX)Intel (INTC)Apple (AAPL)Microsoft (MSFT)Meta Platforms (META)Broadcom (AVGO)Tesla (TSLA)
More on ENOV
Information only, not investment advice. BuyMeWhiskey is not a registered investment adviser or broker-dealer; nothing here is a recommendation to buy, sell or hold any security, and there are no price targets. Data comes from SEC EDGAR filings and public end-of-day market data and may be delayed or contain errors. Verify with the company's filings before making decisions. Prices: end-of-day data as of Oct 15, 2026, 4:00 PM ET. Filings: SEC EDGAR. Updated after every US trading day.